DHJJ Financial Advisors Ltd. Makes New $28,000 Investment in Invesco Pharmaceuticals ETF $PJP

DHJJ Financial Advisors Ltd. purchased a new position in Invesco Pharmaceuticals ETF (NYSEARCA:PJP) in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor purchased 346 shares of the company’s stock, valued at approximately $28,000.

Other institutional investors have also bought and sold shares of the company. LPL Financial LLC grew its position in shares of Invesco Pharmaceuticals ETF by 0.5% during the first quarter. LPL Financial LLC now owns 49,139 shares of the company’s stock valued at $4,256,000 after purchasing an additional 244 shares in the last quarter. Jones Financial Companies Lllp grew its position in shares of Invesco Pharmaceuticals ETF by 11.6% during the first quarter. Jones Financial Companies Lllp now owns 2,428 shares of the company’s stock valued at $210,000 after purchasing an additional 252 shares in the last quarter. Wealth Enhancement Advisory Services LLC grew its position in shares of Invesco Pharmaceuticals ETF by 8.2% during the fourth quarter. Wealth Enhancement Advisory Services LLC now owns 8,364 shares of the company’s stock valued at $691,000 after purchasing an additional 635 shares in the last quarter. Cetera Investment Advisers grew its position in shares of Invesco Pharmaceuticals ETF by 12.7% during the first quarter. Cetera Investment Advisers now owns 6,240 shares of the company’s stock valued at $541,000 after purchasing an additional 702 shares in the last quarter. Finally, Peak Asset Management LLC grew its position in shares of Invesco Pharmaceuticals ETF by 0.6% during the first quarter. Peak Asset Management LLC now owns 132,817 shares of the company’s stock valued at $11,504,000 after purchasing an additional 850 shares in the last quarter.

Invesco Pharmaceuticals ETF Price Performance

Shares of NYSEARCA PJP opened at $95.65 on Friday. The business’s 50 day moving average is $89.83 and its two-hundred day moving average is $83.88. Invesco Pharmaceuticals ETF has a 1-year low of $72.25 and a 1-year high of $95.88. The stock has a market capitalization of $273.56 million, a P/E ratio of 15.59 and a beta of 0.66.

Invesco Pharmaceuticals ETF Profile

PowerShares Dynamic Pharmaceuticals Portfolio (the Fund) is a non-diversified fund. The Fund seeks investment results that correspond generally to the price and yield of the Dynamic Pharmaceuticals Intellidex Index (the Index). The Index evaluates companies based on a variety of investment merit criteria, including fundamental growth, stock valuation, investment timeliness and risk factors.